ScholarIQanswers from OpenAlex & ORCID
C. Paul
ResearcherPublications, citations & collaboration network
C. Paul is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does C. Paul have?
ScholarIQindexed works
C. Paul has 849 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does C. Paul have?
ScholarIQcitation count
C. Paul has 29,140 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of C. Paul?
ScholarIQh-index
C. Paul has an h-index of 92 in OpenAlex.
What is the i10-index of C. Paul?
ScholarIQi10-index
C. Paul has an i10-index of 330 in OpenAlex.
What is the ORCID of C. Paul?
ScholarIQorcid
The ORCID for C. Paul is on the source record.
What is the OpenAlex record for C. Paul?
ScholarIQopenalex
The OpenAlex for C. Paul is on the source record.
What are the most-cited papers on C. Paul?
ScholarIQmost cited works
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth B. Gordon, Jolanta Węgłowska, L. Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco A. Kerdel, April W. Armstrong, Georg Stingl, Alexa B. Kimball, H. Bachelez, Jashin J. Wu, Jeffrey Crowley, Richard G. Langley, Tomasz Blicharski, C. Paul, J.‐P. Lacour, Stephen K. Tyring, Leon Kircik, Sergio Chimenti, Kristina Callis Duffin, Jerry Bagel, John Koo, Gary Aras, Joanne Li, Wenjie Song, Cassandra E. Milmont, Yifei Shi, Ngozi Erondu, Paul Klekotka, Brian L. Kotzin, Ajay Nirula
Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
Mark Lebwohl, H. Bachelez, Jonathan Barker, Giampiero Girolomoni, Arthur Kavanaugh, Richard G. Langley, C. Paul, L. Puig, Kristian Reich, P.C.M. van de Kerkhof
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
C. Paul, Jennifer Clay Cather, Melinda Gooderham, Yves Poulin, Ulrich Mrowietz, C. Ferrandiz, J. Crowley, ChiaChi Hu, R.M. Stevens, Kara N. Shah, R. M. Day, Giampiero Girolomoni, A.B. Gottlieb
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
Andreas Wollenberg, Stéphanie Christen-Zäch, Alain Taı̈eb, C. Paul, Jacob P. Thyssen, Marjolein de Bruin‐Weller, Christian Vestergaard, Julien Sénéschal, Thomas Werfel, Michael J. Cork, B Kunz, Regina Fölster‐Holst, Magdalena Trzeciak, Ulf Darsow, Zsuzsanna Szalai, Mette Deleuran, Laura von Kobyletzki, S. Barbarot, Annice Heratizadeh, Uwe Gieler, DirkJan Hijnen, Stephan Weidinger, L. De Raeve, Åke Svensson, Dagmar Simon, J.‐F. Stalder, Johannes Ring, for the European Task Force on Atopic Dermatitis/EADV Eczema Task Force
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, C. Paul, Andrew Pink, Yoko Kataoka, Chia‐Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana A. Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, Hernán Valdez